Sangamo Therapeutics, Inc. (SGMOQ)
0.161
-0.01
(-3.13%)
USD |
OTCM |
Sep 04, 16:00
Sangamo Therapeutics Cash and Short Term Investments (Annual) : 20.95M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 20.95M |
| December 31, 2024 | 41.92M |
| December 31, 2023 | 81.00M |
| December 31, 2022 | 277.63M |
| December 31, 2021 | 376.55M |
| December 31, 2020 | 641.42M |
| December 31, 2019 | 362.47M |
| December 31, 2018 | 400.13M |
| December 31, 2017 | 243.31M |
| December 31, 2016 | 142.54M |
| December 31, 2015 | 209.00M |
| December 31, 2014 | 179.28M |
| December 31, 2013 | 93.13M |
| December 31, 2012 | 63.55M |
| Date | Value |
|---|---|
| December 31, 2011 | 84.13M |
| December 31, 2010 | 60.28M |
| December 31, 2009 | 84.94M |
| December 31, 2008 | 64.83M |
| December 31, 2007 | 81.09M |
| December 31, 2006 | 53.92M |
| December 31, 2005 | 46.96M |
| December 31, 2004 | 33.26M |
| December 31, 2003 | 43.86M |
| December 31, 2002 | 52.14M |
| December 31, 2001 | 61.59M |
| December 31, 2000 | 63.51M |
| December 31, 1999 | 69.13M |
| December 31, 1998 | 3.058M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 919.37M |
| Oncolytics Biotech, Inc. | 5.202M |
| Sarepta Therapeutics, Inc. | 939.65M |
| Anixa Biosciences, Inc. | 15.17M |
| Vicapsys Life Sciences, Inc. | 0.0026M |